Friday 6 November 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.

Revenue: +5.93%
EPS: +23.1%
Free cash flow: −9.79%
Total debt: −38.9%

Quarter to September 2026, against a year earlier

235.46 3.85 −1.61%

Follow RMD

Alert me

Market cap: $33.7B
P/E: 21.7×
Fwd P/E: 19.6×
Dividend yield: 1.03%
F-score: 6/9
Altman Z: 10.00
Beneish M: −2.59
Dividend safety: 96/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

ResMed Inc. 10-Q filed Oct 30, 2026

Fiscal Q1 2027 · Period ended Sep 30, 2026 · Filed Oct 30, 2026 · accepted 6:11 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Oct 31, 2025: no comparison — the earlier filing's Item cannot be compared

ResMed Inc. 10-Q filed Oct 30, 2026

What changed

Stockrow Weekly